Abstract
The deletion (D) rather than insertion (I) allele of the angiotensin-converting enzyme (ACE) gene is associated with greater ACE activity. We examined: (1) the influence of posture change (recumbent to seated) and acute exercise on serum ACE and angiotensin II (Ang II) activity; (2) the relationship between ACE and Ang II levels; and (3) the influence of ACE genotype on changes in ACE and Ang II levels with posture and exercise. Recreationally active young male Caucasians (10 each of II, ID and DD genotypes) rested for 35 min supine then 15 min upright, took 20 min bicycle ergometric exercise at 70% maximum oxygen uptake, then rested for 40 min. Samples were taken throughout for ACE activity and Ang II levels. Supine ACE levels were dependent upon ACE genotype [24.8 (5.7), 26.9 (4.5), 45.5 (6.4) nmol His-Leu ml−1 min−1; II, ID, DD, respectively; P<0.00005] and thereafter. ACE activity rose with assumption of a seated posture [from 32.4 (10.9) nmol His-Leu ml−1 min−1 to 35.0 (11.5) nmol His-Leu ml−1 min−1, P<0.00001], the absolute rise being independent of genotype [3.22 (1.92), 1.6 (1.6), 2.4 (2.3) nmol His-Leu ml−1 min−1; II, ID, DD; P=0.22], unlike percentage change [12.8 (6.8), 5.6 (5.5), 5.3 (5.0)%; II, ID, DD; P<0.01, and P=0.004 for II vs presence of the D allele]. A further genotype-independent rise occurred with exercise [+2.9 (3.7) units, P<0.0003]. An associated rise in Ang II levels [30.3 (15.9), or 2587.9 (489.76)%, P<0.00001] was independent of ACE genotype or activity. Upright posture increases ACE activity, and this may be influenced by ACE genotype. ACE activity and Ang II levels rise independently with exercise in a non-genotype-dependent fashion.
Similar content being viewed by others
References
Admiraal PJ, Derkx FH, Danser AH, Pieterman H, Schalekamp MA (1990) Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15:44–55
Aldigier JC, Huang H, Dalmay F, Lartigue M, Baussant T, Chassain AP, Leroux-Robert C, Galen FX (1993) Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 21:289–295
Arvay G, Szathmary G, Reuter M (1982) Changes in angiotensin-converting enzyme activity and angiotensin I level in asthmatic and healthy children after submaximal physical work. J Allergy Clin Immunol 69:178–180
Beldent V, Michaud A, Wei L, Chauvet M-T, Corvol P (1993) Proteolytic release of human angiotensin-converting enzyme: localisation of the cleavage site. J Biol Chem 268:26428–26434
Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J (1990) Serum angiotensin-converting enzyme in healthy an sarcoidotic children: comparison with the reference interval for adults. Clin Chem 36:344–346
Bouissou P, Guezennec CY, Galen FX, Defer G, Fiet J, Pesquies PC (1988) Dissociated response of aldosterone from plasma renin activity during prolonged exercise under hypoxia. Horm Metab Res 20:517–521
Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ (1999) Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34:1170–1175
Brown NJ, Blais C Jr, Gandhi SK, Adam A (1998) ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 32:373–377
Chadwick IG, O’Toole L, Morice AH, Yeo WW, Jackson PR, Ramsay LE (1997) Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes. J Cardiovasc Pharmacol 29:485–489
Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin 1-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33–40
Danser AH, Maarten ADH, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H (1995) Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92:1387–1388
Danser AH, Deinum J, Osterop AP, Admiraal PJ, Schalekamp MA (1999) Angiotensin I to angiotensin II conversion in the human forearm and leg: effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertens 17:1867–1872
Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, Jones D (2000) Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 85:575–579
Freudenthaler SM, Lucht I, Schenk T, Brink M, Gleiter CH (2000) Dose-dependent effect of angiotensin II on human erythropoietin production. Pflugers Arch 439:838–844
Fyhrquist F, Dessypris A, Immonen I (1983) Marathon run: effects on plasma renin activity, renin substrate, angiotensin converting enzyme, and cortisol. Horm Metab Res 15:96–99
Gordon SE, Davis BS, Carlson CJ, Booth FW (2001) Ang II is required for optimal overload-induced skeletal muscle hypertrophy Am J Physiol Endocrinol Metab 280: E150–159
Harp JB, Henry SA, DiGirolamo M (2002) Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 10:985–990
Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC (1993) The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 21:455–460
Hilgenfeldt U, Puschner T, Riester U, Finsterle J, Hilgenfeldt JR (1998) Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. Am J Physiol 275: F88–F93
Jalil JE, Ocaranza MP, Piddo AM, Jalil R (1999) Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyle-leucine as substrate. J Lab Clin Med 133:510–506
Kem DC, Brown RD (1990) Renin–from beginning to end. N Eng J Med 323:1136–1137
Kinugawa T, Ogino K, Miyakoda H, Saitoh M, Hisatome I, Fujimoto Y, Yoshida A, Shigemasa C, Sato R (1997) Responses of catecholamines, renin-angiotensin system, and atrial natriuretic peptide to exercise in untrained men and women. Gen Pharmacol 28:225–228
Kosunen KJ, Pakarinen AJ (1976) Plasma renin, angiotensin II, and plasma and urinary aldosterone in running exercise. J Appl Physiol 41:26–29
Kraemer WJ, Fleck SJ, Maresh CM, Ratamess NA, Gordon SE, Goetz KL, Harman EA, Frykman PN, Volek JS, Mazzetti SA, Fry AC, Marchitelli LJ, Patton JF (1999) Acute hormonal responses to a single bout of heavy resistance exercise in trained power lifters and untrained men. Can J Appl Physiol 24:524–537
Lee MA, Paul M, Bohm M, Ganten D (1992) Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol 70:12C–19C
Matsui T, Matsufuji H, Kawasaki T, Osajima Y (1997a) Determination of endogenous peptides with in vitro ACE inhibitory activity in normotensive human plasma by the fluorometric HPLC method. Biosci Biotechnol Biochem 61:1052–1054
Matsui T, Matsufuji H, Tamaya K, Kawasaki T, Osajima Y (1997b) Metabolic behavior of angiotensins in normotensive human plasma in the supine and upright postures Biosci Biotechnol Biochem 61:1814–1818
Metsarinne K (1988) Effect of exercise on plasma renin substrate. Int J Sports Med 9:267–269
Milledge JS, Catley DM (1982) Renin, aldosterone, and converting enzyme during exercise and acute hypoxia in humans. J Appl Physiol 52:320–323
Miura S, Ideishi M, Sakai T, Motoyama M, Kinoshita A, Sasaguri M, Tanaka H, Shindo M, Arakawa K (1994) Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens 12:1177–1181
Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi M-A, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmud P, McEwan JR, McKenna WJ, Humphries S (1997) Association of Angiotensin-Converting Enzyme Gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741–747
Montgomery HE, Marshall RM, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE (1998) Human gene for physical performance. Nature 393:221–222
Montgomery H, Humphries S, Danilov S (2002) Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease? Eur Heart J 23:1083–1086
Musumeci V, Cardillo C, BaroniS, Tutinelli F, Guerrera G, Melina D, Savi L, Folli G (1987) Plasma markers of endothelial cells and platelet activation following handgrip in normals and hypertensive patients. J Clin Hypertens 3:487–499
Novo S, Adamo L, Giamporcaro A, Forte G, Longo B, Gallo VB, Licata G, Strano A (1987) Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs). Agents Actions Suppl 22:339–347
Nystrom F, Karlberg BE, Ohman KP (1997) Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system. J Hum Hypertens 11:301–306
O’Dell SD, Humphries SE, Day IN (1995) Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 73:368–371
Pluto R, Cruze SA, Weiss M, Hotz T, Mandel P, Weicker H (1988) Cardiocirculatory, hormonal, and metabolic reactions to various forms of ergometric tests. Int J Sports Med 9 [Suppl 2]:S79–88
Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Vado A, Bennetton G, Uslenghi E, Piazza A (1998) Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk of coronary stent restenosis. Circulation 97:147–154
Sadhukhan R, Sen GC, Ramchandran R, Sen I (1998) The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc Natl Acad Sci USA 95:138–143
Santhamma KR, Sen I (2000) Specific cellular proteins associate with angiotensin-converting enzyme and regulate its intracellular transport and cleavage-secretion. J Biol Chem 275:23253–23258
Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197–205
Ueda S, Elliott HL, Morton JJ, Connell JM (1995) Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266–1269
Unger T, Schüll B, Rascher W, Lang RE, Ganten D (1982) Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol 31:3063–3070
Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE (2000) The ACE gene and muscle performance. Nature 403:614
Woods DR, Brull D, Montgomery HE (2000) Endurance and the ACE I/D polymorphism. Sci Prog 83:317–336
Xavier-Neto J, Pereira AC, Junqueira ML, Carmona R, Krieger JE (1999) Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium. Hypertension 34:31–38
Acknowledgements
We should like to thank the volunteers who took part. J.S. and H.M. are funded by the Portex Endowment. This work was supported by an unconditional educational grant from Aventis UK. J.S., S.E.H. and J.R.P. are funded by the British Heart Foundation, who also provide core funding for the Centre for Cardiovascular Genetics. These experiments comply with the current United Kingdom law.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woods, D., Sanders, J., Jones, A. et al. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype. Eur J Appl Physiol 91, 342–348 (2004). https://doi.org/10.1007/s00421-003-0993-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-003-0993-1